Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:21 AM
Ignite Modification Date: 2025-12-25 @ 2:21 AM
NCT ID: NCT04794634
Eligibility Criteria: Inclusion Criteria: * Patients having a consultation in the Research and Resources Memory Center of Amiens (RRMC) , * patients registered in the Alzheimer National Bank and having an Alzheimer Disease based on NIA-AA (McKahnn2011)and IWG2 (Dubois et al, 2014) criteria or, having a Lewy body disease based on revised criteria of McKeith et al 2020 * patients having a complete neuropsychological evaluation including a visual inspection time. * patients having a MMSE ≥ 18/30 so as to ensure a good homogeneity of the group and to have an adequate ocular exam's quality. * patients having an available MRI in the CHU's database including a 3DT1 sequence * patients having a visual acuity better than 5/10, spherical refraction of +/- 5D, an astigmatism \< 3D and an applanation IOP \<22mmHg Exclusion Criteria: * Any other neurocognitive disorder * Any other optical neuropathy including glaucoma * All kind of retinal disease (diabetic retinopathy, age-related macular degeneration…) * Diabetes mellitus * Uncontrolled hypertension blood pressure * Any ophthalmological conditions interfering with a good ocular examination or OCT quality (cataract, corneal opacity..) * Severe dementia preventing a good ophthalmological examination * Not consenting patient * Patient with guardianship or curatorship having symptoms preventing a good ophthalmological examination (agitation, unstable ocular fixation)
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT04794634
Study Brief:
Protocol Section: NCT04794634